MRIGlobal

Will we see you at the 2024 Chem Outsourcing Conference this year? We have extensive experience supporting pharmaceutical analysis across a wide variety of intermediates, drug substances, and drug products. We perform analytical method development, phase appropriate validation, product characterization, release and stability testing. Contact our Sr. Director, Aaron Heiss, Ph.D. at [email protected] to schedule time with him and learn more.

10 years ago, the U.S. Department of Defense engaged MRIGlobal to support the response to the West Africa Ebola outbreak. Today, our expertise in field forward diagnostics and global health surveillance position us to support responses to future disease outbreaks. #Ebola

Following several cases of highly pathogenic avian influenza/H5N1 now in dairy cows and several farm workers, we're revisiting this blog from last year. #H5N1

Changes are coming to how IVDs developed in laboratories are regulated! MRIGlobal will provide you with the expertise needed to successfully transition your products to meet FDA’s expectations for compliance. #FDA #LDT #LaboratoryDevelopedTests

The CDC issued a health advisory this week warning of an increased risk of contracting dengue virus in the U.S. this year. On the blog, we profile what's driving this increased risk, highlighting Joe Russell's field work.

The Plague Doctor's PPE is an early example of biosafety, but we’ve come a long way since then. Read more about our commitment to biosafety and biosecurity best practices on the blog --->

It has been two weeks since we launched the new MRIGlobal brand. On the blog, we offer insight into our renewed focus on producing multidisciplinary and innovative solutions to address tomorrow’s important challenges, and how this drove our thinking in development of the new brand. --->

Researchers are putting CRISPR gene editing to work in agriculture, diagnostics, disease therapeutics, and even in the fight against climate change. On this episode of "Science Diction" with Dr. Amy Manning-Bog, Dr. Julie Lucas offers insight into why ensuring its responsible use is critical and how it may help us find new pathogens before they impact human health. #CRISPR

Virologists, do you know how valuable your unpublished safety and quality data might be? Drop by Poster 51 at Poster Session III on June 26th to learn about opportunities for shaping the future of biosafety and biorisk management from Devin Boyles, CPH. #ASV2024

Today’s conflicts around the world highlight the pressing need for continued research into mitigating chemical threats on the battlefield and the home front. Our work in this area improves people’s lives through innovative scientific and engineering research. Read more on the blog --->